RIVASTIGMINE PATCH DEXCEL 9.5 MG24 H

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

RIVASTIGMINE

Dostupné s:

DEXCEL LTD, ISRAEL

ATC kód:

N06DA03

Léková forma:

PATCHES

Složení:

RIVASTIGMINE 13.8 MG

Podání:

TRANSDERMAL

Druh předpisu:

Required

Výrobce:

LUYE PHARMA AG, GERMANY

Terapeutické oblasti:

RIVASTIGMINE

Terapeutické indikace:

Treatment of mild to moderate dementia of the Alzheimer's type.

Datum autorizace:

2022-06-30

Informace pro uživatele

PATIENT PACKAGE INSERT ACCORDING TO PHARMACISTS' REGULATIONS
(PREPARATIONS) – 1986
This medicine can be sold with a physician’s prescription only
RIVASTIGMINE PATCH DEXCEL 4.6 MG/24 H
RIVASTIGMINE PATCH DEXCEL 9.5 MG/24 H
A PATCH FOR USE ON THE SKIN (TRANSDERMAL PATCH)
EACH PATCH CONTAINS:
RIVASTIGMINE PATCH DEXCEL 4.6 MG/24 H: a 4.6 cm
2
transdermal patch containing 6.9 mg
rivastigmine. The release rate of the medicine is: 4.6 mg in 24 hours.
RIVASTIGMINE PATCH DEXCEL 9.5 MG/24 H: a 9.2 cm
2
transdermal patch containing 13.8 mg
rivastigmine. The release rate of the medicine is: 9.5 mg in 24 hours.
Inactive ingredients and allergens in the medicine
–
see section 6 "Additional information".
READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains concise
information about the medicine. If you have any further questions, ask
the doctor or
pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may
harm them, even if you think that their illness is similar.
1.
WHAT IS THE MEDICINE INTENDED FOR?
For the treatment of mild to moderate Alzheimer's dementia (memory
problems).
THERAPEUTIC GROUP: Cholinesterase enzyme inhibitors
(anticholinesterases).
Rivastigmine belongs to a group of substances called cholinesterase
inhibitors. In patients
with Alzheimer’s dementia, certain nerve cells in the brain die, and
cause low levels of the
neurotransmitter acetylcholine (a substance that allows nerve cells to
communicate with each
other). Rivastigmine works by blocking the enzymes that break down
acetylcholine:
acetylcholinesterase and butyrylcholinesterase. By blocking these
enzymes, RIVASTIGMINE
PATCH DEXCEL allows the acetylcholine levels in the brain to be
increased, and helps to
reduce
the symptoms of Alzheimer’s disease.
RIVASTIGMINE PATCH DEXCEL is intended for the treatment of adult
patients with mild and
moderate dementia, a progressive brain disorder that gradually affects
memory, intellectual
ability and behavior.
2.
BEFORE USING THE MEDI